Shilpa Medicare 過去の業績
過去 基準チェック /26
Shilpa Medicareの収益は年間平均-47.2%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間13.4% 6.5%割合で 増加しています。 Shilpa Medicareの自己資本利益率は2.6%であり、純利益率は5%です。
主要情報
-47.2%
収益成長率
-48.5%
EPS成長率
| Pharmaceuticals 業界の成長 | 17.5% |
| 収益成長率 | 6.5% |
| 株主資本利益率 | 2.6% |
| ネット・マージン | 5.0% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You
Sep 12
Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues
Jul 05What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You
Apr 12Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up
Feb 21Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt
Jan 02These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively
Jul 17Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt
Mar 17Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)
Sep 22Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10
Sep 07Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10
Aug 14Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load
Jan 27Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why
Sep 21Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?
Jun 17If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late
May 31Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Mar 07Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year
Feb 20Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?
Jan 26
収支内訳
収支内訳
Shilpa Medicare の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 12,163 | 611 | 3,048 | 0 |
| 30 Jun 24 | 11,839 | 448 | 2,808 | 0 |
| 31 Mar 24 | 11,531 | 319 | 3,025 | 0 |
| 31 Dec 23 | 11,248 | -7 | 2,978 | 0 |
| 30 Sep 23 | 11,008 | -119 | 2,973 | 0 |
| 30 Jun 23 | 10,491 | -321 | 2,873 | 0 |
| 31 Mar 23 | 10,517 | -325 | 2,969 | 0 |
| 31 Dec 22 | 11,286 | 51 | 3,063 | 0 |
| 30 Sep 22 | 11,384 | 213 | 3,054 | 0 |
| 30 Jun 22 | 11,693 | 599 | 2,795 | 0 |
| 31 Mar 22 | 11,469 | 607 | 2,824 | 0 |
| 31 Dec 21 | 10,135 | 395 | 2,692 | 0 |
| 30 Sep 21 | 9,324 | 376 | 2,612 | 0 |
| 30 Jun 21 | 9,156 | 631 | 2,404 | 0 |
| 31 Mar 21 | 9,016 | 1,478 | 2,473 | 0 |
| 31 Dec 20 | 9,135 | 1,739 | 2,281 | 0 |
| 30 Sep 20 | 9,591 | 2,213 | 2,168 | 0 |
| 30 Jun 20 | 9,698 | 2,267 | 2,027 | 0 |
| 31 Mar 20 | 9,082 | 1,562 | 2,043 | 0 |
| 31 Dec 19 | 8,876 | 1,455 | 2,022 | 0 |
| 30 Sep 19 | 8,241 | 1,029 | 1,983 | 0 |
| 30 Jun 19 | 6,962 | 944 | 1,826 | 0 |
| 31 Mar 19 | 7,337 | 1,123 | 1,834 | 0 |
| 31 Dec 18 | 7,693 | 1,193 | 1,776 | 0 |
| 30 Sep 18 | 7,814 | 1,281 | 1,704 | 0 |
| 30 Jun 18 | 8,211 | 1,167 | 1,566 | 0 |
| 31 Mar 18 | 7,894 | 1,052 | 1,555 | 0 |
| 31 Dec 17 | 7,756 | 1,133 | 1,498 | 0 |
| 30 Sep 17 | 7,731 | 1,149 | 1,422 | 0 |
| 30 Jun 17 | 7,787 | 1,190 | 1,319 | 0 |
| 31 Mar 17 | 7,795 | 1,076 | 1,330 | 0 |
| 31 Dec 16 | 7,565 | 1,048 | 1,158 | 0 |
| 30 Sep 16 | 7,735 | 1,153 | 1,092 | 0 |
| 30 Jun 16 | 7,369 | 1,024 | 1,007 | 0 |
| 31 Mar 16 | 7,166 | 1,083 | 934 | 0 |
| 31 Dec 15 | 6,867 | 886 | 1,170 | 159 |
| 30 Sep 15 | 6,430 | 776 | 1,113 | 159 |
| 30 Jun 15 | 6,234 | 728 | 844 | 0 |
| 31 Mar 15 | 6,138 | 737 | 855 | 0 |
| 31 Dec 14 | 6,145 | 731 | 997 | 95 |
| 30 Sep 14 | 6,143 | 798 | 991 | 95 |
| 30 Jun 14 | 5,966 | 787 | 723 | 0 |
| 31 Mar 14 | 5,714 | 757 | 913 | 95 |
| 31 Dec 13 | 5,025 | 664 | 767 | 46 |
質の高い収益: SHILPAMEDは 高品質の収益 を持っています。
利益率の向上: SHILPAMED過去に利益を上げました。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: SHILPAMEDの収益は過去 5 年間で年間47.2%減少しました。
成長の加速: SHILPAMEDは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。
収益対業界: SHILPAMED昨年収益を上げたため、昨年の収益成長をPharmaceuticals業界 ( 20% ) と比較することは困難です。
株主資本利益率
高いROE: SHILPAMEDの 自己資本利益率 ( 2.6% ) は 低い とみなされます。